Donor-Derived Metastatic Melanoma and Checkpoint Inhibition. [electronic resource]
Producer: 20180418Description: 1551-1554 p. digitalISSN:- 1873-2623
- Allografts -- pathology
- Antibodies, Monoclonal -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Checkpoint Kinase 1 -- antagonists & inhibitors
- Checkpoint Kinase 2 -- antagonists & inhibitors
- Humans
- Imidazoles -- therapeutic use
- Kidney -- pathology
- Kidney Neoplasms -- drug therapy
- Kidney Transplantation -- adverse effects
- Liver Neoplasms -- drug therapy
- Lung Neoplasms -- drug therapy
- Male
- Melanoma -- drug therapy
- Middle Aged
- Nivolumab
- Oximes -- therapeutic use
- Pyridones -- therapeutic use
- Pyrimidinones -- therapeutic use
- Tissue Donors
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.